Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Keshav Karki"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e5544e80a7a343b5b3c9b4d24e2a1a0f
Piperlongumine downregulates Sp1, Sp3, Sp4 and Sp-regulated genes: effects of Tiron.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad543c0c54bf83a8d266e989a7b006cf
https://doi.org/10.1158/1940-6207.22532851
https://doi.org/10.1158/1940-6207.22532851
Autor:
Stephen Safe, Alexandra Lacey, Keshav Karki, Kumaravel Mohankumar, Indira Jutooru, Ravi Kasiappan
Supplementary Figure 1 from Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4511e132ccab8bd8738d2244b1eb1d13
https://doi.org/10.1158/1541-7786.22512600.v1
https://doi.org/10.1158/1541-7786.22512600.v1
Autor:
Stephen Safe, Alexandra Lacey, Keshav Karki, Kumaravel Mohankumar, Indira Jutooru, Ravi Kasiappan
Methyl 2-trifluoromethyl-3,11-dioxo-18β-olean-1,12-dien-3-oate (CF3DODA-Me) is derived synthetically from glycyrrhetinic acid, a major component of licorice, and this compound induced reactive oxygen species (ROS) in RD and Rh30 rhabdomyosarcoma (RM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0e20141fcacfa52f3fcd452ab4361f5
https://doi.org/10.1158/1541-7786.c.6540291.v1
https://doi.org/10.1158/1541-7786.c.6540291.v1
Autor:
Stephen Safe, Alexandra Lacey, Keshav Karki, Kumaravel Mohankumar, Indira Jutooru, Ravi Kasiappan
Primers for ChIP assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471d0336811a20f8ab7e1a333ec3b0b8
https://doi.org/10.1158/1541-7786.22512594
https://doi.org/10.1158/1541-7786.22512594
PD-L1 is expressed in tumor cells and its interaction with PD-1 plays an important role in evading immune surveillance; this can be overcome using PD-L1 or PD-1 immunotherapy antibodies. This study reports a novel approach for targeting PD-L1. In hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9f4a77ddcfe32eb60f83714d6995a9
https://doi.org/10.1158/0008-5472.c.6512221
https://doi.org/10.1158/0008-5472.c.6512221
Supplemental Figure S4. NR4A1 antagonist inhibit 4T1-luc cell growth and invasion, and induce apoptosis. 4T1-Luc cells were treated with different concentrations of CDIM8 or Cl-OCH3 and effects on cell proliferation (A), invasion (B) and induction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a99ab4fbc55636b9f1eadae6ae8e07
https://doi.org/10.1158/0008-5472.22426087.v1
https://doi.org/10.1158/0008-5472.22426087.v1
Supplemental Table S1. Summary of reagents, antibodies, immune staining sources, oligonucleotides and primers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7b6ea29bcf63d5cea8941fe1af4024
https://doi.org/10.1158/0008-5472.22426081
https://doi.org/10.1158/0008-5472.22426081
Autor:
Phanourios Tamamis, Keshav Karki, Stephen Safe, Robert S. Chapkin, Farrhin Nowshad, Laurie A. Davidson, Hyejin Park, Un-Ho Jin, Asuka A. Orr, Arul Jayaraman, Clinton D. Allred
Publikováno v:
Toxicol Sci
Hydroxylated chalcones are phytochemicals which are biosynthetic precursors of flavonoids and their 1,3-diaryl-prop-2-en-1-one structure is used as a scaffold for drug development. In this study, the structure-dependent activation of aryl hydrocarbon